Back to results
TerminatedPhase 1Phase 2

A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors

NCT05716295

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Sarah Cannon Research Institute (Florida Cancer Specialists)

Sarasota, Florida, United States

+5 additional locations

View on ClinicalTrials.gov
A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors — TrialFind